Columbus Community Clinical Oncology Program

Recent papers from Columbus Community Clinical Oncology Program

1. Lycopene and survival in patients with stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702.Journal of Clinical Oncology · 2026
2. The Hidden Life of Stars: Embedded Beginnings to Asymptotic Giant Branch Endings in the PHANGS–JWST Sample. I. Catalog of Mid-infrared SourcesThe Astrophysical Journal Supplement Series · 2026
3. Localized Deviations from the CO–Polycyclic Aromatic Hydrocarbon Relation in PHANGS-JWST Galaxies: Faint Polycyclic Aromatic Hydrocarbon Emission or Elevated CO Emissivity?The Astrophysical Journal · 2026
4. Abstract 5038: Associations of WCRF/AICR recommendations with survival and chemotherapy outcomes in colon cancer: CALGB/SWOG 80702 (Alliance)Cancer Research · 2026
5. Abstract PS1-08-03: Three-year outcomes following five-fraction sbrt for apbi in early-stage breast cancer: cosmesis, functional status, and local controlClinical Cancer Research · 2026
6. Physical activity and molecular residual disease (MRD) in stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702.Journal of Clinical Oncology · 2026
7. Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (alliance)JNCI Journal of the National Cancer Institute · 2025
8. Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Journal of Clinical Oncology · 2025
9. Polycyclic Aromatic Hydrocarbon and CO(2–1) Emission at 50–150 pc Scales in 70 Nearby GalaxiesThe Astrophysical Journal · 2025
10. Inflammation, Physical Activity, and Disease-Free Survival in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)JNCI Journal of the National Cancer Institute · 2024
11. Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)Journal of Clinical Oncology · 2024
12. PHANGS-JWST: Data-processing Pipeline and First Full Public Data ReleaseThe Astrophysical Journal Supplement Series · 2024
13. A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)2024
14. Cloud-scale molecular gas properties of the antennae merger: A comparative study with PHANGS-ALMA galaxies and NGC 3256Monthly Notices of the Royal Astronomical Society · 2024
15. Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)Clinical Cancer Research · 2023
16. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerJAMA Oncology · 2023
17. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)Journal of Clinical Oncology · 2022
18. Molecular Cloud Populations in the Context of Their Host Galaxy Environments: A Multiwavelength PerspectiveThe Astronomical Journal · 2022
19. Genome-wide host methylation profiling of anal and cervical carcinomaPLoS ONE · 2021
20. Functional Disability Among Older Versus Younger Adults With Advanced Non–Small-Cell Lung CancerJCO Oncology Practice · 2021